Monroe Terilyn J. 4

What Happened

• Terilyn J. Monroe, Chief People Officer of Guardant Health (GH), received a grant of 17,040 restricted stock units (RSUs) reported on Form 4 for the 2026-03-11 transaction. The award is reported as an acquisition (derivative) at $0.00 — i.e., compensation stock units, not a cash purchase.

Key Details

• Transaction date: 2026-03-11; Form 4 filed: 2026-03-13 (appears timely).
• Grant: 17,040 RSUs at $0.00 (derivative award; code A).
• Vesting (per footnote F1): 33% vests on April 1, 2027; remaining 67% vests in equal quarterly installments over the following two years.
• Shares owned after transaction: Not specified in this filing.
• Footnotes: F1 = vesting schedule above; F2 = not applicable for RSUs.

Context

• RSUs are a promise to deliver shares upon vesting, so Monroe does not immediately receive tradable shares at grant. Such awards are typically compensation and do not necessarily indicate a personal market buy/sell decision. Taxes and any withholding obligations generally occur at vesting, not at grant.